Literature DB >> 17938644

Association between prostate-specific antigen and leptin, adiponectin, HbA1c or C-peptide among African-American and Caucasian men.

J H Fowke1, C M Matthews, M S Buchowski, L B Signorello, S S Chang, M S Cookson, W J Blot.   

Abstract

Prior studies report slightly lower prostate-specific antigen (PSA) levels among obese men. To understand this effect, we investigated the association between PSA and blood HbA1c, C-peptide, leptin and adiponectin levels in African-American (AA) (n=121) and Caucasian (CA) (n=121) men. Among AA men, PSA levels decreased with increasing C-peptide levels (PSA=0.99, 0.93, 0.75 and 0.53 ng ml(-1) across quartiles of C-peptide, respectively; P(trend)=0.005). Among CA men, PSA levels decreased with increasing HbA1c (PSA=0.84, 0.73, 0.77 and 0.45 ng ml(-1) across quartiles of HbA1c, respectively; P(trend)=0.005). This may suggest that metabolic disturbances related to metabolic syndrome or diabetes affect the ability to detect early-stage prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17938644     DOI: 10.1038/sj.pcan.4501022

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  14 in total

Review 1.  Urological aspects of the metabolic syndrome.

Authors:  Jan Hammarsten; Ralph Peeker
Journal:  Nat Rev Urol       Date:  2011-08-02       Impact factor: 14.432

2.  Metformin use and risk of prostate cancer: results from the REDUCE study.

Authors:  Tom Feng; Xizi Sun; Lauren E Howard; Adriana C Vidal; Alexis R Gaines; Daniel M Moreira; Ramiro Castro-Santamaria; Gerald L Andriole; Stephen J Freedland
Journal:  Cancer Prev Res (Phila)       Date:  2015-09-09

3.  Association between C-peptide concentration and prostate cancer incidence in the CLUE II cohort study.

Authors:  Gabriel Y Lai; Kathy J Helzlsouer; Sandra L Clipp; Nader Rifai; Elizabeth A Platz
Journal:  Cancer Prev Res (Phila)       Date:  2010-09-21

4.  Racial variation in umbilical cord blood leptin concentration in male babies.

Authors:  Gabriel Y Lai; Sabine Rohrmann; Tanya Agurs-Collins; Catherine G Sutcliffe; Gary Bradwin; Nader Rifai; Jessica L Bienstock; Elizabeth A Platz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-02-09       Impact factor: 4.254

5.  Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3.

Authors:  Jay H Fowke; Charles E Matthews; Herbert Yu; Qiuyin Cai; Sarah Cohen; Maciej S Buchowski; Wei Zheng; William J Blot
Journal:  Endocr Relat Cancer       Date:  2010-01-29       Impact factor: 5.678

6.  Diabetes and prostate cancer screening in black and white men.

Authors:  Maureen Sanderson; Jay H Fowke; Loren Lipworth; Xijing Han; Flora Ukoli; Ann L Coker; William J Blot; Margaret K Hargreaves
Journal:  Cancer Causes Control       Date:  2013-07-17       Impact factor: 2.506

7.  Poor glycemic control is associated with reduced prostate specific antigen concentrations in men with type 1 diabetes.

Authors:  Aruna V Sarma; James Hotaling; Rodney L Dunn; Patricia A Cleary; Barbara H Braffett; Catherine Kim; Catherine Martin; William Herman; Patricia Gatcomb; Alan M Jacobson; Sarah K Holt; Hunter Wessells
Journal:  J Urol       Date:  2014-09-11       Impact factor: 7.450

8.  The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer.

Authors:  Jennifer H Gunter; Amy A Lubik; Ian McKenzie; Michael Pollak; Colleen C Nelson
Journal:  Adv Urol       Date:  2012-04-03

9.  Obesity, body composition, and prostate cancer.

Authors:  Jay H Fowke; Saundra S Motley; Raoul S Concepcion; David F Penson; Daniel A Barocas
Journal:  BMC Cancer       Date:  2012-01-18       Impact factor: 4.430

10.  New players for advanced prostate cancer and the rationalisation of insulin-sensitising medication.

Authors:  Jennifer H Gunter; Phoebe L Sarkar; Amy A Lubik; Colleen C Nelson
Journal:  Int J Cell Biol       Date:  2013-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.